We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.39B
AUM Growth
+$344M
Cap. Flow
+$229M
Cap. Flow %
16.52%
Top 10 Hldgs %
16.24%
Holding
318
New
46
Increased
121
Reduced
103
Closed
19

Sector Composition

Rank Sector Weight
1 Industrials 19.51%
2 Technology 15.09%
3 Consumer Discretionary 11.18%
4 Healthcare 10.43%
5 Consumer Staples 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRC
26
DELISTED
MRC Global
MRC
$17M 1.23%
526,770
+122,561
+30% +$3.69M
FCFS icon
27
FirstCash
FCFS
$9.02B
$16.6M 1.2%
268,457
+60,689
+29% +$3.67M
ESND
28
DELISTED
Essendant Inc.
ESND
$16.6M 1.19%
360,860
+83,651
+30% +$3.68M
HXL icon
29
Hexcel
HXL
$7.89B
$15.8M 1.14%
354,667
-30,888
-8% -$1.3M
ACH
30
Accendra Health
ACH
$227M
$15.6M 1.13%
427,909
+95,742
+29% +$3.51M
SXT icon
31
Sensient Technologies
SXT
$5.54B
$15.6M 1.13%
322,082
+73,510
+30% +$3.66M
INVN
32
DELISTED
Invensense Inc
INVN
$15.6M 1.12%
749,717
+170,286
+29% +$3.05M
AIN icon
33
Albany International
AIN
$1.75B
$15.4M 1.11%
+427,571
New +$15.3M
CATY icon
34
Cathay General Bancorp
CATY
$4.29B
$15.2M 1.1%
569,351
+131,614
+30% +$3.34M
HLX icon
35
Helix Energy Solutions
HLX
$1.37B
$14.9M 1.08%
+643,484
New +$15M
HNGR
36
DELISTED
Hanger Inc.
HNGR
$14.9M 1.07%
377,809
+84,319
+29% +$3.09M
PPO
37
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$14.7M 1.06%
378,122
+85,193
+29% +$3.36M
VIAV icon
38
Viavi Solutions
VIAV
$9.6B
$14.7M 1.06%
1,984,729
+433,229
+28% +$3.29M
POLY
39
DELISTED
Plantronics, Inc.
POLY
$14.6M 1.06%
315,068
+72,601
+30% +$3.27M
VRA icon
40
Vera Bradley
VRA
$99.2M
$14.6M 1.05%
605,672
+315,992
+109% +$7.24M
MTZ icon
41
MasTec
MTZ
$21.4B
$14.5M 1.05%
442,682
+98,643
+29% +$3.12M
EHC icon
42
Encompass Health
EHC
$11B
$14.1M 1.02%
531,250
-141,659
-21% -$3.94M
SN
43
DELISTED
Sanchez Energy Corporation
SN
$14.1M 1.02%
574,061
+140,734
+32% +$3.74M
HAE icon
44
Haemonetics
HAE
$3.8B
$12.8M 0.92%
302,993
+67,873
+29% +$2.79M
KOP icon
45
Koppers
KOP
$981M
$12.7M 0.92%
278,606
+63,470
+30% +$2.88M
LNCE
46
DELISTED
Snyders-Lance, Inc.
LNCE
$12.4M 0.9%
433,940
+96,836
+29% +$2.77M
SSI
47
DELISTED
Stage Stores Inc
SSI
$12.3M 0.88%
551,730
+126,551
+30% +$2.64M
DBD
48
DELISTED
Diebold Nixdorf Incorporated
DBD
$9.51M 0.69%
287,941
+64,122
+29% +$2M
SLXP
49
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$9.03M 0.65%
100,382
+22,961
+30% +$1.83M
SBNY
50
DELISTED
Signature Bank
SBNY
$9.02M 0.65%
83,935
-19,911
-19% -$2.04M

Similar funds

Rice Hall James & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Rice Hall James & Associates held 318 positions worth $1.39B, up 33% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Rice Hall James & Associates deployed $229M of net new capital in Q4 2013, opening 46 new positions and adding to 121 existing holdings. Its largest new stake was Albany International: 427,571 shares worth $15.4M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Encompass Health, an estimated $3.94M trimmed.

  • Rice Hall James & Associates's largest Q4 2013 buy was Albany International: 427,571 shares worth $15.4M.
  • Rice Hall James & Associates added most to Integrated Device Technology I in Q4 2013, an estimated $10M increase.
  • Rice Hall James & Associates's biggest Q4 2013 reduction was Encompass Health, cutting an estimated $3.94M.
  • Rice Hall James & Associates fully exited Wendy's in Q4 2013, selling an estimated $12.3M.
  • Rice Hall James & Associates's ten largest holdings make up 16% of its $1.39B portfolio in Q4 2013.
  • Rice Hall James & Associates opened 46 new positions and closed 19 in Q4 2013.
  • Rice Hall James & Associates's portfolio value rose 33% quarter-over-quarter to $1.39B.

Based on Rice Hall James & Associates's 13F filing for Q4 2013, filed 11 Feb 2014.